6-Methoxyflavone Induces S-phase Arrest Through the CCNA2/CDK2/p21CIP1 Signaling Pathway in HeLa Cells

Overview

Journal Bioengineered

Date 2022 Mar 5

PMID 35246013

Authors

Chaihong Zhang

Yuchong Quan

Lijuan Yang

Yingying Bai

Yongxiu Yang

Affiliations

Soon will be listed here.

Abstract

This study aimed to elucidate the specific anticancer mechanism of 6-methoxyflavone in HeLa cells. A total of 178 putative targets of 6-methoxyflavone were obtained from the PharmMapper database. Microarray analyses, transcriptome sequencing analyses, functional enrichment analyses, and gene set enrichment analyses were performed to preliminarily explore the roles and mechanisms of the 178 targets in cervical cancer. Cell counting kit-8, cell cycle assays, polymerase chain reactions, and western blotting were used to clarify the mechanism of action of 6-methoxyflavone. Molecular docking and noncovalent interaction analyses were performed to further confirm the mechanism of action in three-dimensional structures. Functional enrichment analyses and gene set enrichment analyses indicated that high mRNA expression of cyclin A2 (CCNA2) and cyclin-dependent kinase 2 (CDK2) stimulated cell cycle progression in cervical cancer. Cell proliferation and cycle assays, transcriptome sequencing, polymerase chain reactions, and western blotting revealed that 6-methoxyflavone inhibited HeLa cell proliferation and induced S-phase arrest via the CCNA2/CDK2/ cyclin-dependent kinase inhibitor 1A (p21CIP1) pathway. Molecular docking and noncovalent interaction analyses showed that 6-methoxyflavone had the strongest affinity toward, inhibitory effect on, and noncovalent interactions with CDK2, and that the combination of CDK2 and CCNA2 enhanced these effects. An analysis of clinical characteristics showed that 6-methoxyflavone might be related to six clinicopathological parameters of cervical cancer patients. 6-Methoxyflavone induces S-phase arrest in HeLa cells via the CCNA2/CDK2/p21CIP1 pathway.

Citing Articles

Mechanistic Insights into the Anticancer Potential of Methoxyflavones Analogs: A Review.

Aidiel M, Abdul Mutalib M, Ramasamy R, Nik Ramli N, Tang S, Adam S Molecules. 2025; 30(2).

PMID: 39860214 PMC: 11768088. DOI: 10.3390/molecules30020346.

A new herbal extract carbon nanodot nanomedicine for anti-renal cell carcinoma through the PI3K/AKT signaling pathway.

Tian N, Liu X, He X, Liu Y, Xiao L, Wang P RSC Adv. 2024; 14(49):36437-36450.

PMID: 39545169 PMC: 11562028. DOI: 10.1039/d4ra07181f.

Identification of key genes associated with cervical cancer based on bioinformatics analysis.

Yang X, Zhou M, Luan Y, Li K, Wang Y, Yang X BMC Cancer. 2024; 24(1):897.

PMID: 39060960 PMC: 11282596. DOI: 10.1186/s12885-024-12658-z.

References

Shendge A, Chaudhuri D, Mandal N . The natural flavones, acacetin and apigenin, induce Cdk-Cyclin mediated G2/M phase arrest and trigger ROS-mediated apoptosis in glioblastoma cells. Mol Biol Rep. 2021; 48(1):539-549. DOI: 10.1007/s11033-020-06087-x. View

Wang X, Shen Y, Wang S, Li S, Zhang W, Liu X . PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res. 2017; 45(W1):W356-W360. PMC: 5793840. DOI: 10.1093/nar/gkx374. View

Kim S, Chen J, Cheng T, Gindulyte A, He J, He S . PubChem in 2021: new data content and improved web interfaces. Nucleic Acids Res. 2020; 49(D1):D1388-D1395. PMC: 7778930. DOI: 10.1093/nar/gkaa971. View

Bardou P, Mariette J, Escudie F, Djemiel C, Klopp C . jvenn: an interactive Venn diagram viewer. BMC Bioinformatics. 2014; 15:293. PMC: 4261873. DOI: 10.1186/1471-2105-15-293. View

Sozmen M, Tunca R, Dag Erginsoy S . Cyclin A expression is associated with apoptosis and mitosis in murine 3-methylcholanthrene-induced fibrosarcomas. Exp Toxicol Pathol. 2008; 61(1):41-9. DOI: 10.1016/j.etp.2008.05.009. View

van der Horst J, Siebers A, Bulten J, Massuger L, Kok I . Increasing incidence of invasive and in situ cervical adenocarcinoma in the Netherlands during 2004-2013. Cancer Med. 2017; 6(2):416-423. PMC: 5313636. DOI: 10.1002/cam4.971. View

Fu X, Li H, Yang K, Chen D, Tang H . The important tumor suppressor role of PER1 in regulating the cyclin-CDK-CKI network in SCC15 human oral squamous cell carcinoma cells. Onco Targets Ther. 2016; 9:2237-45. PMC: 4846057. DOI: 10.2147/OTT.S100952. View

Tong J, Yu H, Li J, Zhou J, Ma X, Yang J . Short-term recurrence and distant metastasis following robotic-assisted radical hysterectomy with pelvic lymphadenectomy and chemoradiotherapy for a stage IB1 cervical adenocarcinoma: A case report and literature review. Medicine (Baltimore). 2019; 98(17):e15387. PMC: 6831419. DOI: 10.1097/MD.0000000000015387. View

Subramanian A, Tamayo P, Mootha V, Mukherjee S, Ebert B, Gillette M . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102(43):15545-50. PMC: 1239896. DOI: 10.1073/pnas.0506580102. View

10.

Adasme M, Linnemann K, Bolz S, Kaiser F, Salentin S, Haupt V . PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA. Nucleic Acids Res. 2021; 49(W1):W530-W534. PMC: 8262720. DOI: 10.1093/nar/gkab294. View

11.

Qu M, Li J, Yuan L . Uncovering the action mechanism of homoharringtonine against colorectal cancer by using network pharmacology and experimental evaluation. Bioengineered. 2021; 12(2):12940-12953. PMC: 8810123. DOI: 10.1080/21655979.2021.2012626. View

12.

Gu P, Zhang M, Zhu J, He X, Yang D . Suppression of CDCA3 inhibits prostate cancer progression via NF‑κB/cyclin D1 signaling inactivation and p21 accumulation. Oncol Rep. 2021; 47(2). PMC: 8759108. DOI: 10.3892/or.2021.8253. View

13.

Xiao Y, Liang M, Liu C, Wang Y, Zeng Y, Zhou J . Overexpression of P16 reversed the MDR1-mediated DDP resistance in the cervical adenocarcinoma by activating the ERK1/2 signaling pathway. Cell Div. 2019; 14:6. PMC: 6612198. DOI: 10.1186/s13008-019-0048-6. View

14.

Zhang Q, Wang L, Cao L, Wei T . Novel circular RNA circATRNL1 accelerates the osteosarcoma aerobic glycolysis through targeting miR-409-3p/LDHA. Bioengineered. 2021; 12(2):9965-9975. PMC: 8809938. DOI: 10.1080/21655979.2021.1985343. View

15.

DAlessio R, Bargiotti A, Metz S, Brasca M, Cameron A, Ermoli A . Benzodipyrazoles: a new class of potent CDK2 inhibitors. Bioorg Med Chem Lett. 2005; 15(5):1315-9. DOI: 10.1016/j.bmcl.2005.01.023. View

16.

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

17.

Tunyasuvunakool K, Adler J, Wu Z, Green T, Zielinski M, Zidek A . Highly accurate protein structure prediction for the human proteome. Nature. 2021; 596(7873):590-596. PMC: 8387240. DOI: 10.1038/s41586-021-03828-1. View

18.

Zuo Z, He L, Duan X, Peng Z, Han J . Glycyrrhizic acid exhibits strong anticancer activity in colorectal cancer cells via SIRT3 inhibition. Bioengineered. 2021; 13(2):2720-2731. PMC: 8974138. DOI: 10.1080/21655979.2021.2001925. View

19.

Huang D, Sherman B, Lempicki R . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. DOI: 10.1038/nprot.2008.211. View

20.

Liu Z, Liu L, Sun R, Liu C . BAF45D knockdown decreases cell viability, inhibits colony formation, induces cell apoptosis and S-phase arrest in human pancreatic cancer cells. Biosci Biotechnol Biochem. 2020; 84(6):1146-1152. DOI: 10.1080/09168451.2020.1717923. View